TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle
- Vogler, Thomas O;
- Wheeler, Joshua R;
- Nguyen, Eric D;
- Hughes, Michael P;
- Britson, Kyla A;
- Lester, Evan;
- Rao, Bhalchandra;
- Betta, Nicole Dalla;
- Whitney, Oscar N;
- Ewachiw, Theodore E;
- Gomes, Edward;
- Shorter, James;
- Lloyd, Thomas E;
- Eisenberg, David S;
- Taylor, J Paul;
- Johnson, Aaron M;
- Olwin, Bradley B;
- Parker, Roy
- et al.
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324568/Abstract
A dominant histopathological feature in neuromuscular diseases, including amyotrophic lateral sclerosis and inclusion body myopathy, is cytoplasmic aggregation of the RNA-binding protein TDP-43. Although rare mutations in TARDBP-the gene that encodes TDP-43-that lead to protein misfolding often cause protein aggregation, most patients do not have any mutations in TARDBP. Therefore, aggregates of wild-type TDP-43 arise in most patients by an unknown mechanism. Here we show that TDP-43 is an essential protein for normal skeletal muscle formation that unexpectedly forms cytoplasmic, amyloid-like oligomeric assemblies, which we call myo-granules, during regeneration of skeletal muscle in mice and humans. Myo-granules bind to mRNAs that encode sarcomeric proteins and are cleared as myofibres mature. Although myo-granules occur during normal skeletal-muscle regeneration, myo-granules can seed TDP-43 amyloid fibrils in vitro and are increased in a mouse model of inclusion body myopathy. Therefore, increased assembly or decreased clearance of functionally normal myo-granules could be the source of cytoplasmic TDP-43 aggregates that commonly occur in neuromuscular disease.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.